

Cover Story
By Matthew Bin Han Ong
The Bidens are now official players in the realm of oncopolitics.
By Paul Goldberg and Matthew Bin Han Ong
In Brief


Drugs & Targets


Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - “There is no safe harbor:” FY26 funding bill collapses after ICE shooting of Alex Pretti
- Fifth time’s a charm? Mikaela Naylon Give Kids a Chance Act is included in FY26 spending bill
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- An oncologist navigates terminal sarcoma, insurmountable debt, and “a legacy of grief”
How colleagues and Fargo, ND, neighbors came together to help the Erickson-Abou Zahrs - House passes three-year extension of ACA subsidies with bipartisan support













